S2
processes were similar to the synthesis of AFHs. The reaction was carried out at 20 °C for 3 h. heterostructures: 10 nm Ag NPs (~20 mg) dissolved in 10 mL ODE, 5 mL OA and 0.2 mL OAm solution then degassed under Ar at 70 °C for 30 min in a four-necked flask. The mixture was heated to 150 °C, and 0.15 mL of Fe(CO) 5 were injected into the solution and heated to 300 °C. After 1 h, the products were collected and washed for 3 times.
Synthesis of

Phase transfer and biofunctionalization: mPEG-COOH (MW: 2000) was
used to modify the synthesized heterostructures. Typically, synthesized nanoparticles (20 mg) were dispersed into dichloromethane (15 mL), followed by adding in mPEG-COOH (20 mg), after stirring for 10 h, ethanol (20 mL) was added to collect the NPs by centrifuging (15000 rpm for 10 min). The NPs were washed with ethanol and water once, and finally dissolved in DI water through ultrasonic dispersion for further use.
MR imaging measurement:
The MR imaging measurements of JAFHs in water solution were performed on a 3.0T clinical MRI scanner (GE Signa 3.0 T).
JAFHs at given Fe concentrations of 0, 0.0308, 0.0616, 0.1232, 0.2465, 0.4929 mM were dispersed in 1mL of DI water (18.2 MΩ) in 1.5 mL centrifuge tubes and placed into the MRI scanner. T 2 weighted fast spin-echo (FR-FSE) sequence with parameters of TR=3000 ms, TE=102 ms, slice thickness=3.0 mm was used and the images were analyzed at the workstation provided by GE heathcare. Figure S12b ) and JAFHs (shown in Figure 2c ) with both 10 nm Ag; (b) the comparison of Ag NPs (shown in Figure S12a ) and SAFHs (shown in 
